Login / Signup

Successful treatment with efgartigimod as an add-on therapy in acute attack of anti-AQP4 antibody-positive NMOSD: a case report.

Shi-Qi HuangZhen-Hua YuanYe HongTeng JiangHong-Dong ZhaoJian-Quan Shi
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)
This case suggests that efgartigimod is a potentially effective add-on therapy in acute attacks of AQP4-IgG-positive NMOSD.
Keyphrases
  • liver failure
  • respiratory failure
  • drug induced
  • aortic dissection
  • intensive care unit
  • bone marrow
  • mechanical ventilation
  • replacement therapy